• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自恶性疟原虫顶端膜抗原1(AMA-1)的与人类肝细胞特异性相互作用的合成肽。

Synthetic peptides from Plasmodium falciparum apical membrane antigen 1 (AMA-1) specifically interacting with human hepatocytes.

作者信息

Valbuena J, Rodríguez L, Vera R, Puentes A, Curtidor H, Cortés J, Rosas J, Patarroyo M E

机构信息

Fundación Instituto de Inmunología de Colombia, Universidad Nacional de Colombia, Cra 50 No. 26-00, 020304 Bogota, Cundinamarca, Colombia.

出版信息

Biochimie. 2006 Oct;88(10):1447-55. doi: 10.1016/j.biochi.2006.05.005. Epub 2006 Jun 5.

DOI:10.1016/j.biochi.2006.05.005
PMID:16765504
Abstract

Plasmodium falciparum apical membrane antigen 1 (AMA-1) is expressed during both the sporozoite and merozoite stage of the parasite's life cycle. The role placed by AMA-1 during sporozoite invasion of hepatocytes has not been made sufficiently clear to date. Identifying the sequences involved in binding to hepatocytes is an important step towards understanding the structural basis for sporozoite-hepatocyte interaction. Binding assays between P. falciparum AMA-1 peptides and HepG2 cell were performed in this study to identify possible AMA-1 functional regions. Four AMA-1 high activity binding peptides (HABPs) bound specifically to hepatocytes: 4310 ((74)QHAYPIDHEGAEPAPQEQNL(93)), 4316 ((194)TLDEMRHFYKDNKYVKNLDE(213)), 4321 ((294)VVDNWEKVCPRKNLQNAKFGY(313)) and 4332 ((514)AEVTSNNEVVVKEEYKDEYA(533)). Their binding to these cells became saturable and resistant to treatment with neuraminidase. Most of these peptides were located in AMA-1 domains I and III, these being target regions for protective antibody responses. These peptides interacted with 36 and 58 kDa proteins on the erythrocyte surface. Some of the peptides were found in exposed regions of the AMA-1 protein, thereby facilitating their interaction with host cells. It is thus probable that AMA-1 regions defined by the four peptides mentioned above are involved in sporozoite-hepatocyte interaction.

摘要

恶性疟原虫顶端膜抗原1(AMA-1)在疟原虫生命周期的子孢子和裂殖子阶段均有表达。迄今为止,AMA-1在子孢子入侵肝细胞过程中所起的作用尚未完全明确。确定与肝细胞结合的序列是理解子孢子与肝细胞相互作用结构基础的重要一步。本研究进行了恶性疟原虫AMA-1肽与HepG2细胞之间的结合试验,以确定可能的AMA-1功能区。四种AMA-1高活性结合肽(HABP)特异性结合肝细胞:4310((74)QHAYPIDHEGAEPAPQEQNL(93))、4316((194)TLDEMRHFYKDNKYVKNLDE(213))、4321((294)VVDNWEKVCPRKNLQNAKFGY(313))和4332((514)AEVTSNNEVVVKEEYKDEYA(533))。它们与这些细胞的结合具有饱和性,且对神经氨酸酶处理具有抗性。这些肽大多位于AMA-1结构域I和III,这两个结构域是保护性抗体反应的靶区域。这些肽与红细胞表面36 kDa和58 kDa的蛋白质相互作用。部分肽位于AMA-1蛋白的暴露区域,从而便于其与宿主细胞相互作用。因此,上述四种肽所界定的AMA-1区域可能参与子孢子与肝细胞的相互作用。

相似文献

1
Synthetic peptides from Plasmodium falciparum apical membrane antigen 1 (AMA-1) specifically interacting with human hepatocytes.来自恶性疟原虫顶端膜抗原1(AMA-1)的与人类肝细胞特异性相互作用的合成肽。
Biochimie. 2006 Oct;88(10):1447-55. doi: 10.1016/j.biochi.2006.05.005. Epub 2006 Jun 5.
2
Peptides from the Plasmodium falciparum STEVOR putative protein bind with high affinity to normal human red blood cells.来自恶性疟原虫STEVOR推定蛋白的肽与正常人红细胞具有高亲和力结合。
Peptides. 2005 Jul;26(7):1133-43. doi: 10.1016/j.peptides.2005.01.013. Epub 2005 Feb 23.
3
Identification of peptides with high red blood cell and hepatocyte binding activity in the Plasmodium falciparum multi-stage invasion proteins: PfSPATR and MCP-1.在恶性疟原虫多阶段入侵蛋白PfSPATR和MCP-1中鉴定具有高红细胞和肝细胞结合活性的肽段。
Biochimie. 2008 Nov-Dec;90(11-12):1750-9. doi: 10.1016/j.biochi.2008.08.003. Epub 2008 Sep 13.
4
Identifying Plasmodium falciparum EBA-175 homologue sequences that specifically bind to human erythrocytes.鉴定与人类红细胞特异性结合的恶性疟原虫EBA-175同源序列。
Biochem Biophys Res Commun. 2004 Sep 3;321(4):835-44. doi: 10.1016/j.bbrc.2004.07.034.
5
Sporozoite and liver stage antigen Plasmodium falciparum peptides bind specifically to human hepatocytes.恶性疟原虫子孢子与肝期抗原肽可特异性结合人肝细胞。
Vaccine. 2004 Mar 12;22(9-10):1150-6. doi: 10.1016/j.vaccine.2003.09.029.
6
Identifying merozoite surface protein 4 and merozoite surface protein 7 Plasmodium falciparum protein family members specifically binding to human erythrocytes suggests a new malarial parasite-redundant survival mechanism.鉴定恶性疟原虫裂殖子表面蛋白4和裂殖子表面蛋白7家族中与人类红细胞特异性结合的蛋白成员,提示了一种新的疟原虫冗余生存机制。
J Med Chem. 2007 Nov 15;50(23):5665-75. doi: 10.1021/jm070773z. Epub 2007 Oct 18.
7
Structures of phage-display peptides that bind to the malarial surface protein, apical membrane antigen 1, and block erythrocyte invasion.与疟疾表面蛋白、顶膜抗原1结合并阻断红细胞入侵的噬菌体展示肽的结构。
Biochemistry. 2003 Aug 26;42(33):9915-23. doi: 10.1021/bi034376b.
8
Identifying Plasmodium falciparum merozoite surface antigen 3 (MSP3) protein peptides that bind specifically to erythrocytes and inhibit merozoite invasion.鉴定与红细胞特异性结合并抑制裂殖子入侵的恶性疟原虫裂殖子表面抗原3(MSP3)蛋白肽。
Protein Sci. 2005 Jul;14(7):1778-86. doi: 10.1110/ps.041304505.
9
Studies of Plasmodium falciparum rhoptry-associated membrane antigen (RAMA) protein peptides specifically binding to human RBC.恶性疟原虫棒状体相关膜抗原(RAMA)蛋白肽与人类红细胞特异性结合的研究。
Vaccine. 2008 Feb 6;26(6):853-62. doi: 10.1016/j.vaccine.2007.11.086. Epub 2007 Dec 26.
10
Identifying Plasmodium falciparum merozoite surface protein-10 human erythrocyte specific binding regions.鉴定恶性疟原虫裂殖子表面蛋白-10的人红细胞特异性结合区域。
Biochimie. 2005 May;87(5):461-72. doi: 10.1016/j.biochi.2005.01.001.

引用本文的文献

1
Plasmodium vivax ligand-receptor interaction: PvAMA-1 domain I contains the minimal regions for specific interaction with CD71+ reticulocytes.恶性疟原虫配体-受体相互作用:PvAMA-1 结构域 I 包含与 CD71+网织红细胞特异性相互作用的最小区域。
Sci Rep. 2017 Aug 30;7(1):9616. doi: 10.1038/s41598-017-10025-6.
2
An Extended Surface Loop on Toxoplasma gondii Apical Membrane Antigen 1 (AMA1) Governs Ligand Binding Selectivity.弓形虫顶端膜抗原1(AMA1)上的一个延伸表面环决定配体结合选择性。
PLoS One. 2015 May 8;10(5):e0126206. doi: 10.1371/journal.pone.0126206. eCollection 2015.
3
Host cell invasion by apicomplexan parasites: the junction conundrum.
顶复门寄生虫对宿主细胞的侵袭:连接难题
PLoS Pathog. 2014 Sep 18;10(9):e1004273. doi: 10.1371/journal.ppat.1004273. eCollection 2014 Sep.
4
O-GlcNAc modification of the anti-malarial vaccine candidate PfAMA1: in silico-defined structural changes and potential to generate a better vaccine.疟原虫 AMA1 抗疟疫苗候选物的 O-GlcNAc 修饰:计算机定义的结构变化及其产生更好疫苗的潜力。
Mol Biol Rep. 2012 Apr;39(4):4663-72. doi: 10.1007/s11033-011-1258-4. Epub 2011 Oct 22.